{"database": "openregs", "table": "federal_register", "rows": [["2021-25381", "Effective Date of Requirement for Premarket Approval for Blood Lancets", "Rule", "The Food and Drug Administration (FDA, Agency, or we) is issuing a final order to require the filing of a premarket approval application (PMA) or notice of completion of a product development protocol (PDP) following the reclassification of multiple use blood lancets for multiple patient use from class I to class III.", "2021-11-22", 2021, 11, "https://www.federalregister.gov/documents/2021/11/22/2021-25381/effective-date-of-requirement-for-premarket-approval-for-blood-lancets", "https://www.govinfo.gov/content/pkg/FR-2021-11-22/pdf/2021-25381.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA, Agency, or we) is issuing a final order to require the filing of a premarket approval application (PMA) or notice of completion of a product development protocol (PDP) following the reclassification of multiple...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2021-25381"], "units": {}, "query_ms": 16.093320096842945, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}